Inspire Medical Systems, Inc.
NYQ: INSPLive Quote
About Inspire Medical Systems, Inc.
Healthcare
Medical Devices
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
📊 Fundamental Analysis
Inspire Medical Systems, Inc. demonstrates a healthy profit margin of 15.9%.
The company recently reported 12.2% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 19.8%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $54.02, INSP currently trades near the bottom of its 52-week range (5%), indicating potential value or weakness (Range: $48.30 - $163.35).
💰 Valuation Insight
INSP trades at a 55.8% discount (PE: 11.05), which may represent a value opportunity given the sector average of 25.00. Analysts anticipate some earnings pressure, with a higher forward PE.
🏥 Financial Health
⚠️
Profit Margin
Moderate
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
⚠️
Return on Equity
Moderate
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$1.22B
Trailing P/E
11.05
Forward P/E
20.75
Beta (5Y)
0.86
52W High
$163.35
52W Low
$48.30
Avg Volume
1.27M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App